Title

Discovery of Novel Boronates; Structural Building Blocks of Potential Enzyme Inhibitors

Document Type

Poster

Event Website

https://source2022.sched.com/

Start Date

16-5-2022

End Date

16-5-2022

Keywords

Boron, Medicine, Chemistry

Abstract

As bacteria and viruses continue to mutate and develop multidrug resistance, the urgency for developing more effective treatments increases. While this increase in mutation can be somewhat mitigated by the modification of current medicinal treatments, more long-term solutions involve the use of more novel remedies. Past investigations with the use of boron-containing compounds have shown significant potential as potent therapeutic compounds. Currently, there are five boron-containing FDA-approved medications. This supports the potential effectiveness of boron-containing chemical compounds and it indicates the need for more in-depth research, discovery, and development. Currently, the Fabry research group focuses its efforts on the synthesis of boron-modified inhibitors of HIV-1 aspartic protease. This work involves a homologation reaction followed by a nucleophilic bimolecular substitution. The obtained novel boronates are characterized using nuclear magnetic resonance (NMR) spectroscopy and gas chromatography/mass spectrometry (GC/MS). The ultimate goal of this project is to create a diverse library of novel boron compounds and to test the limits of synthetic boron chemistry.

Faculty Mentor(s)

Levente Fabry-Asztalos

Department/Program

Biological Sciences

Additional Mentoring Department

Chemistry

Additional Mentoring Department

Funding from Central OUR Grants

Additional Files

Ditter, Kaitlyn SOURCE poster.pptx (1850 kB)
Poster

Share

COinS
 
May 16th, 12:00 AM May 16th, 12:00 AM

Discovery of Novel Boronates; Structural Building Blocks of Potential Enzyme Inhibitors

As bacteria and viruses continue to mutate and develop multidrug resistance, the urgency for developing more effective treatments increases. While this increase in mutation can be somewhat mitigated by the modification of current medicinal treatments, more long-term solutions involve the use of more novel remedies. Past investigations with the use of boron-containing compounds have shown significant potential as potent therapeutic compounds. Currently, there are five boron-containing FDA-approved medications. This supports the potential effectiveness of boron-containing chemical compounds and it indicates the need for more in-depth research, discovery, and development. Currently, the Fabry research group focuses its efforts on the synthesis of boron-modified inhibitors of HIV-1 aspartic protease. This work involves a homologation reaction followed by a nucleophilic bimolecular substitution. The obtained novel boronates are characterized using nuclear magnetic resonance (NMR) spectroscopy and gas chromatography/mass spectrometry (GC/MS). The ultimate goal of this project is to create a diverse library of novel boron compounds and to test the limits of synthetic boron chemistry.

https://digitalcommons.cwu.edu/source/2022/COTS/38